Statistics for 1-Aryl-3-[4-(thieno[3,2-d]pyrimidin-4-yloxy)phenyl]ureas as VEGFR-2 tyrosine kinase inhibitors: Synthesis, biological evaluation, and molecular modelling studies
Total visits
| views | |
|---|---|
| 1-Aryl-3-[4-(thieno[3,2-d]pyrimidin-4-yloxy)phenyl]ureas as VEGFR-2 tyrosine kinase inhibitors: Synthesis, biological evaluation, and molecular modelling studies | 578 |
Total visits per month
| views | |
|---|---|
| January 2025 | 4 |
| February 2025 | 2 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| Artigo 164.pdf(legacy) | 333 |
| Artigo 164.pdf | 9 |
| BRI-revised.doc(legacy) | 1 |
Top country views
| views | |
|---|---|
| United States | 186 |
| Germany | 115 |
| Portugal | 60 |
| China | 43 |
| United Kingdom | 41 |
| Russia | 36 |
| Austria | 21 |
| France | 15 |
| Brazil | 6 |
| Canada | 6 |
| European Union | 5 |
| Sweden | 5 |
| Slovenia | 5 |
| Belarus | 4 |
| Netherlands | 4 |
| Italy | 3 |
| Japan | 3 |
| South Korea | 3 |
| Poland | 3 |
| Turkey | 3 |
| Switzerland | 1 |
| Denmark | 1 |
| Hong Kong SAR China | 1 |
| Ireland | 1 |
| Latvia | 1 |
| Romania | 1 |
| South Africa | 1 |